z-logo
open-access-imgOpen Access
Vaccination of Mice and Cattle with Plasmid DNA Encoding the Mycobacterium bovis Antigen MPB83
Author(s) -
Mark A. Chambers,
H. M. Vordermeier,
Adam O. Whelan,
Nicola J. Commander,
Ricardo E. Tascon,
Douglas B. Lowrie,
R. Glyn Hewinson
Publication year - 2000
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/313875
Subject(s) - mycobacterium bovis , dna vaccination , immunogenicity , vaccination , antigen , virology , tuberculosis vaccines , mycobacterium tuberculosis , medicine , microbiology and biotechnology , immunity , immunology , bcg vaccine , immune system , tuberculosis , biology , immunization , pathology
A scientific review of bovine tuberculosis in Great Britain has concluded that the development of a cattle vaccine holds the best prospect for long-term disease control. Recent reports of successful DNA vaccination against Mycobacterium tuberculosis in small animal models have raised the possibility of using a similar strategy to produce vaccines against Mycobacterium bovis infection in cattle. To test this possibility, BALB/c mice were immunized with DNA encoding the M. bovis antigen MPB83. The mice responded to vaccination with a mixed IgG1/IgG2a response to the antigen and were protected from intravenous challenge with virulent M. bovis to a similar extent as those vaccinated with bacille Calmette-Guérin. The immunogenicity of the DNA vaccine in cattle was tested, after having established that DNA encoding MPB83 was immunogenic and elicited protective immunity in mice. In these studies, vaccinated animals had strong proliferative responses to MPB83.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom